FDA Approved: TEMSIROLIMUS — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved Fresenius Kabi USA, LLC's temsirolimus injection as an original generic application (ANDA) for the treatment of advanced renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• TEMSIROLIMUS INJECTION (temsirolimus)

Snippet

ORIG AP for TEMSIROLIMUS (TEMSIROLIMUS)